Antigenic hepatitis A virus structures may be produced in Escherichia coli

Area of Science:

• Virology
• Microbiology
• Structural Biology

Background:

• Hepatitis A virus (HAV) is a significant human pathogen.
• Previous challenges existed in producing sufficient quantities of HAV structural components for research.
• Understanding HAV capsid assembly is crucial for vaccine development.

Purpose of the Study:

• To achieve the synthesis of hepatitis A virus (HAV) 14S pentamers and 70S empty capsids.
• To investigate the self-assembly properties of HAV pentamers in vitro.
• To evaluate the immunogenicity and neutralizing capacity of the synthesized HAV structures.

Main Methods:

• Expression of the complete hepatitis A virus (HAV) genome in Escherichia coli for extended periods (>4 hours).
• Isolation and purification of 14S pentameric and 70S empty capsid structures.
• In vitro self-assembly assays of HAV pentamers.
• Immunization studies using synthesized HAV structures.
• Antibody characterization for recognition and neutralization of infectious HAV.

Main Results:

• Successful synthesis of 14S pentamers and 70S empty capsids of HAV in E. coli.
• Demonstrated in vitro self-assembly of HAV 14S pentamers into 70S capsids.
• Generated antibodies that specifically recognized HAV structures.
• Confirmed that induced antibodies possessed significant HAV-neutralizing activity.

Conclusions:

• The expression system in E. coli enables the production of functional HAV empty capsids.
• HAV pentamers can self-assemble into complete capsids, mimicking the native structure.
• These synthesized HAV structures are promising candidates for developing effective vaccines against hepatitis A.